Characteristic** | None/Trace | One-Two Pluses | p-value |
N | 252 (96.2) | 10 (3.8) | - |
Males | 93 (95.9) | 4 (4.1) | - |
Females | 159 (96.4) | 6 (3.6) | 0.84 |
Age (Mean, sd) | 43.7 (15.5) | 44.2 (15.3) | 0.93 |
Age Group, N (%) |
|
|
|
20 - 29 | 59 (96.7) | 2 (3.3) | - |
30 - 39 | 48 (96) | 2 (4) | - |
40 - 49 | 47 (94) | 3 (6) | - |
50 - 59 | 41 (100) | - | - |
60 - 69 | 36 (94.7) | 2 (5.3) | - |
≥70 | 21 (95.5) | 1 (4.5) | 0.77* |
BMI (mean, sd) | 25.9 (5.4) | 22.8 (3.3) | 0.07 |
SBP (mean, sd) | 134.1 (24.5) | 128.6 (21.2) | 0.49 |
DBP (mean, sd) | 82.8 (15.8) | 71.3 (9.2) | 0.02 |
FBS (mean sd) | 94.2 (26.9) | 86.7 (12) | 0.38 |
Medical History, N (%) |
|
| |
Diabetes | 10 (4.1) | - | 0.41* |
Hypertension | 8 (3.9) | 2 (3.4) | 0.87* |
Stroke | 10 (3.9) | - | 0.65* |
Substance Use, N (%) |
|
| |
Alcohol Use | 2 (2.2) | 8 (4.7) | 0.33 |
Tobacco Use | 6 (2.7) | 4 (10.8) | 0.02 |
Primary Source of Drugs, N (%) |
|
|
|
Open Market | 49 (96.1) | 2 (3.9) | - |
Hospital/Pharmacy | 203 (96.2) | 8 (3.8) | 0.95 |